Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 20 for “"Lu-177"”.

  1. Lu-177 Automated Quantification Capabilities of Siemens Symbia Intevo 16.

    The use of Lu-177 to treat metastatic prostate cancer and neuroendocrine tumours was introduced to Sir Charles Gairdner Hospital (SCGH) in 2018. Along with its introduction came an interest in dosimetry using absolute quantification. The installation of a new SPECT/CT (Siemens Symbia Intevo) with …

    adelaide Repository record for Lu-177 Automated Quantification Capabilities of Siemens Symbia Intevo 16. (opens in a new tab)

  2. Dosimetry to evaluate the effect of Phosphoromidon on Lu-177-RM2

    … formed will eventually combine to form larger cellular masses or "tumors." These tumors are split into two main categories known as "malignant" and "benign." Benign tumors do not spread into nearby tissue and can generally be easily removed. Malignant tumors or "cancerous tumors" can spread into …

    missouri Repository record for Dosimetry to evaluate the effect of Phosphoromidon on Lu-177-RM2 (opens in a new tab)

  3. Biokinetic Modeling and Dosimetry of Radiopharmaceutical Extravasation in Lu-177-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer

    … (mCRPC) patients undergoing treatment with Lu-177‑PSMA therapy. A compartmental biokinetic model was constructed by appending an extravasation compartment to an established Lu-177‑PSMA framework, with transfer rates fitted from clinical literature. Using the Medical Internal Radiation …

    gatech Repository record for Biokinetic Modeling and Dosimetry of Radiopharmaceutical Extravasation in Lu-177-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (opens in a new tab)

  4. Development of a Practical Lu-177 Activity Calibration Protocol for Clinical Nuclear Medicine: Dosimetric Impact Analysis and Implementation Tools

    Lutetium-177 (Lu-177) is widely used in radionuclide therapy, where accurate activity measurement prior to administration is essential for safe and effective treatment delivery. However, variability in dose calibrator response due to measurement conditions and source geometry remains a practical …

    vcu Repository record for Development of a Practical Lu-177 Activity Calibration Protocol for Clinical Nuclear Medicine: Dosimetric Impact Analysis and Implementation Tools (opens in a new tab)

  5. Συγκριτική ανάλυση δοσιμετρίας απορροφούμενων δόσεων ακτινοβολίας στην πυρηνική ιατρική: μελέτη της θεραπείας με Lu-177 χρησιμοποιώντας πολλαπλές υπολογιστικές μεθόδους

    … αμφότεροι υποβληθέντες σε θεραπεία με Λουτέσιο-177. Στο πλαίσιο της μελέτης εφαρμόστηκαν έξι διακριτές μέθοδοι υπολογισμού (Phantom, Body Mass, Organ Mass, Local Energy Deposition, FFT Convolution, Monte Carlo), αξιοποιώντας δεδομένα από πολυχρονικές σαρώσεις SPECT, εικόνες CT και τα λογισμικά …

    athens Repository record for Συγκριτική ανάλυση δοσιμετρίας απορροφούμενων δόσεων ακτινοβολίας στην πυρηνική ιατρική: μελέτη της θεραπείας με Lu-177 χρησιμοποιώντας πολλαπλές υπολογιστικές μεθόδους (opens in a new tab)

  6. Αξιολόγηση της χορήγησης σημασμένου με LU-177 DOTATATE μετά από καθετηριασμό της ηπατικής αρτηρίας σε νευροενδοκρινούς χαρακτήρα ηπατικές μεταστάσεις

    Purpose: The aim of this study is to evaluate the effectiveness of Lu-177-DOTA-TATE infusions after selective catheterization of the hepatic artery in inoperable liver metastasized sst2 receptor-positive neuroendo-crine tumours due to the effect of β- emission, minimising in parallel the toxicity …

    greece Repository record for Αξιολόγηση της χορήγησης σημασμένου με LU-177 DOTATATE μετά από καθετηριασμό της ηπατικής αρτηρίας σε νευροενδοκρινούς χαρακτήρα ηπατικές μεταστάσεις (opens in a new tab)

  7. GPU-ENABLED MONTE CARLO SIMULATION AND QUANTITATIVE ACTIVITY RECONSTRUCTION FOR LIMITED-ANGLE LU-177 IMAGING WITH A PHOTON-COUNTING DETECTOR

    Quantitative imaging of Lu-177 activity distribution after radiopharmaceutical therapy is needed to characterize time-dependent biodistribution and support patient-specific dosimetry. This thesis investigated the feasibility of limited-angle quantitative Lu-177 imaging using photon-counting …

    jhu Repository record for GPU-ENABLED MONTE CARLO SIMULATION AND QUANTITATIVE ACTIVITY RECONSTRUCTION FOR LIMITED-ANGLE LU-177 IMAGING WITH A PHOTON-COUNTING DETECTOR (opens in a new tab)

  8. Κλινική αξιολόγηση του λογισμικού εσωτερικής δοσιμετρίας QDOSE+ σε περιπτώσεις ασθενών υπό θεραπεία με Lu-177: σύγκριση με το λογισμικό PLANET Onco Dose

    … εικόνες SPECT/CT από θεραπείες με Lu 177 και εξετάζοντας διαφορές σε όγκο, αθροιστική ενεργότητα και απορροφούμενη δόση. Παράλληλα, διερευνήθηκε η επίδραση της μείωσης των χρονικών σημείων λήψης από τέσσερα σε τρία στο QDOSE+, η επίδραση της κοινής τμηματοποίησης στα δύο λογισμικά, …

    athens Repository record for Κλινική αξιολόγηση του λογισμικού εσωτερικής δοσιμετρίας QDOSE+ σε περιπτώσεις ασθενών υπό θεραπεία με Lu-177: σύγκριση με το λογισμικό PLANET Onco Dose (opens in a new tab)

  9. Challenges Of Lutetium-177 Metastable Concentration In Radiopharmaceutical Waste

    Lutetium-177 (Lu-177) is an upcoming radiopharmaceutical with commercial use recently approved for cancer treatment by the Federal Drug Administration (FDA). During production, a contaminate, Lutetium-177 metastable (Lu-177m), can also be produced. The concentration of Lu-177m will vary greatly …

    uab Repository record for Challenges Of Lutetium-177 Metastable Concentration In Radiopharmaceutical Waste (opens in a new tab)

  10. Zusammenhang zwischen physikalischer Dosimetrie und DNA Doppelstrangbrüchen in Lymphozyten nach Radionuklidtherapie

    … Körper intern, im Gegensatz zur externen Bestrahlung bei der Strahlentherapie. Das Verteilungsmuster der verabreichten Aktivität im Körper wird durch die chemischen und physikalischen Eigenschaften des Radiopharmakons bestimmt. Außerdem sind die Aktivität und die Art der Anreicherung …

    wurz-thes Repository record for Zusammenhang zwischen physikalischer Dosimetrie und DNA Doppelstrangbrüchen in Lymphozyten nach Radionuklidtherapie (opens in a new tab)

  11. Radiolabeled Somatostatin receptor analogs in neuroendocrine tumor

    … of NEN. DOTA-X labeled with beta emitter Lu-177 enables perfect implementation of receptor based radionuclide therapy but the direct relationship to the biokinetics of Ga-68 DOTA-X still remains an open question. With this background, the present research work tried to answer the following …

    fu-berlin Repository record for Radiolabeled Somatostatin receptor analogs in neuroendocrine tumor (opens in a new tab)

  12. Theranostische Radiopharmaka – Translation vom Labortisch bis zur klinischen Anwendung

    … of coordinating radionuclides such as Ga-68, Lu-177 and Au-198. These complexes were evaluated for their stability, coordination behavior, and cytotoxic potential, representing a foundation for future theranostic applications with gold-based radiopharmaceuticals. The second part of the thesis …

    fu-berlin Repository record for Theranostische Radiopharmaka – Translation vom Labortisch bis zur klinischen Anwendung (opens in a new tab)

  13. A multiscale model of tumor growth, pharmacokinetics and radiobiology for radiopharmaceutical therapy optimization

    … tumor growth and the radiobiological effects of Lu-177 radiopharmaceutical therapy (RPT) on tumors using a computationally efficient implementation. The role of this work in the field of theranostics and RPT is to advance our understanding of the complex dynamics involved in the interaction …

    ubc Repository record for A multiscale model of tumor growth, pharmacokinetics and radiobiology for radiopharmaceutical therapy optimization (opens in a new tab) Download PDF for A multiscale model of tumor growth, pharmacokinetics and radiobiology for radiopharmaceutical therapy optimization (opens in a new tab)

  14. Vergleich des strahlenverstärkenden Effekts des PARP-Inhibitors Olaparib auf unterschiedliche Strahlenqualitäten an einem Prostatakarzinom-Zellmodell

    … stellen heutzutage ein wirksames Behandlungsmodell für mehrere Tumorerkrankungen dar. Aufgrund der langjährigen Erfolge in der Anwendung der Radioligandtherapie beim Prostatakarzinom mit dem β-Strahler 177Lu-PSMA und dem α-Strahler 225Ac-PSMA kann die Nuklearmedizin einen neuen …

    qucosa-diss

  15. Optimising Molecular Radionuclide Therapy: The Role of Quantitative SPECT/CT & PET/CT and Radiation Dosimetry

    … treatments such as [131I] NaI-Sodium iodide and [177Lu] Lu - DOTA-TATE.<br/><br/>This study aims to investigate:<br/>• The comparative results of quantitative SPECT/CT & PET/CT imaging.<br/>• Whether serial changes in PET and SPECT-derived standardised uptake value (SUV) are correlated in patients …

    kings Repository record for Optimising Molecular Radionuclide Therapy: The Role of Quantitative SPECT/CT & PET/CT and Radiation Dosimetry (opens in a new tab) Download PDF for Optimising Molecular Radionuclide Therapy: The Role of Quantitative SPECT/CT & PET/CT and Radiation Dosimetry (opens in a new tab)

  16. Determination of Patient Specific S-Values Correlated with Noninvasive Patient Attributes

    … around spatial variances. In the MIRD schema S values denote the mean absorbed dose to a target volume (organ) per unit activity in a source region (organ). The S values are based on phantom models for specific radionuclides, in the MIRD schema they are separable from the kinetic aspects of …

    ecu Repository record for Determination of Patient Specific S-Values Correlated with Noninvasive Patient Attributes (opens in a new tab)

  17. Nuclear medicine: policy context for differences between Europe and the United States

    … in the regions, these documents were evaluated according to their content and publication date. The content analysis was focused on the type of practices described: diagnostic, general, or therapy, as well as the type of radioactive material (or radioactive isotopes) used in such …

    gatech Repository record for Nuclear medicine: policy context for differences between Europe and the United States (opens in a new tab)